Usana Health Sciences Falls After Lowering Full: year outlook

USANA Health Sciences

06/07/2022 22:55

** Shares of nutritional supplements maker USANA Health
Sciences  USNA.N  down ~10% at $89.11 in extended trade
    ** Trims FY net sales outlook to $1.01 bln to $1.06 bln from
prior range of $1.1 bln to $1.2 bln; lowers EPS outlook to $3.85
to $4.45 from $5.00 to $5.70  urn:newsml:reuters.com:*:nBw7zgCC2a
    ** "Inflationary pressures have persisted across several
areas of our business" - Co 
    ** Co adds Q2 sales performance was below expectations,
impacted by COVID-related lockdowns, restrictions in mainland
China and other markets
    ** YTD, USNA down 24.4%

 (Reporting by Nathan Gomes in Bengaluru)
 ((Nathan.Gomes@thomsonreuters.com;))